Access and Utilization of New Antidepressant and Antipsychotic Medications. D. Methodology


The present analysis was developed based on published literature, pharmaceutical claims, and primary research with stakeholders. It focuses on antidepressants and antipsychotics as general classes of pharmacotherapy, with emphasis on agents introduced to the US market after 1988. Chapters III -- V rely primarily on published literature and primary interviews. Chapter VI relies on Medicaid pharmaceutical claims, while Chapter VII relies on published literature. A description of each type of source follows.​